Showing 301 - 320 results of 581 for search '(( 19 a decrease ) OR ( 10 ((meter decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.17s Refine Results
  1. 301
  2. 302

    Effect of Verbal Encouragement on Performance and Affective Responses in Male Sport Science Students during Sprint Modalities by Sahli, Faten

    Published 2024
    “…The assessed parameters comprised physical performance, rating of perceived exertion (RPE), and a feeling scale. Post hoc test analysis indicates a significant increase in physical performance during VETS and VESS conditions compared to the control condition due to a decrease in sprint in line 20 m (VETS: p < 0.001, d = 0.55; VESS: p = 0.016, d = 0.41), sprint 10*2 (VETS: p < 0.001, d = 0.64; VESS: p = 0.05, d = 0.36), and sprint L (VETS: p = 0.001, d = 1.19) times compared to the control condition. …”
    Get full text
    Get full text
  3. 303
  4. 304
  5. 305
  6. 306
  7. 307

    Caffeine use or napping to enhance repeated sprint performance after partial sleep deprivation: Why not both? by Romdhani, Mohamed

    Published 2021
    “…Purpose: To compare the effect of a 20-minute nap opportunity (N20), a moderate dose of caffeine (CAF; 5 mg·kg-1), or a moderate dose of caffeine before N20 (CAF+N) as possible countermeasures to the decreased performance and the partial sleep deprivation-induced muscle damage. …”
    Get full text
    Get full text
    Get full text
  8. 308
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313
  14. 314
  15. 315
  16. 316

    Unraveling the future productivity burden of cardiovascular disease in Qatar: Investigating the modifiable risk factors control in type 2 diabetes by Abushanab, Dina

    Published 2025
    “…AimsInsufficient risk factor control can lead to a loss of millions of productivity-adjusted life years (PALYs). …”
    Get full text
    Get full text
    Get full text
    article
  17. 317
  18. 318
  19. 319

    Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide. by Sara, Sokary

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7%, 0.5mg dose lowered HbA1c by 1.2–1.5%, while the 1.0 mg dose reduced it by 1.4–1.8%. …”
    Get full text
    Get full text
    Get full text
    article
  20. 320